{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:27:32Z","timestamp":1793165252468,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["apjon.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asia-Pacific Journal of Oncology Nursing"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.apjon.2024.100597","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T23:07:55Z","timestamp":1727737675000},"page":"100597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cardiotoxicity in people undergoing cancer treatment - the role of the oncology nurse"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6385-8600","authenticated-orcid":false,"given":"Geraldine A.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Reehal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"41","key":"10.1016\/j.apjon.2024.100597_bib1","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international cardio-oncology society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.apjon.2024.100597_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/eurheartj\/ehz935","article-title":"Cardiology care delivered to cancer patients: the results of a questionnaire survey by the council for cardio oncology and council for cardiology practice of the European society of cardiology","volume":"41","author":"Asteggiano","year":"2020","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.apjon.2024.100597_bib3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/eurjpc\/zwaa054","article-title":"Anticoagulation in patients with atrial fibrillation and active cancer an international survey on patient management","volume":"28","author":"Boriani","year":"2021","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"10.1016\/j.apjon.2024.100597_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.hlc.2023.04.301","article-title":"When cancer and cardiovascular disease intersect: the challenge and the opportunity of cardio-oncology","volume":"33","author":"Sverdlov","year":"2024","journal-title":"Heart Lung Circ"},{"issue":"1","key":"10.1016\/j.apjon.2024.100597_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjonc-2023-000090","article-title":"Cardiovascular health: an important component of cancer survivorship","volume":"2","author":"Cleary","year":"2023","journal-title":"BMJ Oncology"},{"issue":"1","key":"10.1016\/j.apjon.2024.100597_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1188\/21.CJON.93-96","article-title":"Cardio-Oncology A continually evolving subspecialty in oncology nursing","volume":"25","author":"Fadol","year":"2021","journal-title":"Clin J Oncol Nurs"},{"issue":"3","key":"10.1016\/j.apjon.2024.100597_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/1534484305278283","article-title":"Writing integrative literature reviews: guidelines and examples","volume":"4","author":"Torraco","year":"2005","journal-title":"Hum Resour Dev Rev"},{"key":"10.1016\/j.apjon.2024.100597_bib8","unstructured":"Cancer research UK. Causes of cancer and reducing your risk. Causes of cancer | How to reduce the risk of cancer (cancerresearchuk.org). Accessed 1 August 2024."},{"issue":"48","key":"10.1016\/j.apjon.2024.100597_bib9","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","article-title":"A\u00a0population-based study of cardiovascular disease mortality risk in US cancer patients","volume":"40","author":"Sturgeon","year":"2019","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.apjon.2024.100597_bib10","first-page":"113","article-title":"Does cardiovascular mortality overtake cancer mortality during cancer survivorship? An English retrospective cohort study","volume":"4","author":"Strongman","year":"2022","journal-title":"Cardio Oncology"},{"key":"10.1016\/j.apjon.2024.100597_bib11","unstructured":"National Cancer Institute. Statistics and graphs. Statistics and Graphs | Division of Cancer Control and Population Sciences (DCCPS). Accessed 1 August 2024."},{"issue":"18","key":"10.1016\/j.apjon.2024.100597_bib12","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehaa006","article-title":"Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry","volume":"41","author":"Lopez-Sendon","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apjon.2024.100597_bib13","author":"Gevaert","year":"2022","journal-title":"EHJ Acute cardiovascular Care"},{"issue":"8","key":"10.1016\/j.apjon.2024.100597_bib14","first-page":"947","volume":"10","author":"Gevaert","year":"2021"},{"issue":"11","key":"10.1016\/j.apjon.2024.100597_bib15","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/ejhf.1920","volume":"22","author":"Lyon","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.apjon.2024.100597_bib16","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/ejhf.2017","article-title":"Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the cardio-oncology study group of the heart failure association and the cardio-oncology council of the European society of cardiology","volume":"22","author":"Pudil","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"18","key":"10.1016\/j.apjon.2024.100597_bib17","article-title":"Cardiovascular toxicity related to cancer treatment: a pragmatic approach to the American and European cardio-oncology guidelines","volume":"9","author":"Alexandre","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.apjon.2024.100597_bib18","unstructured":"Asteggiano R. End of cancer therapy and long-term follow-up risk assessment Part 1: end of therapy risk assessment and management. Website: End of cancer therapy and long-term follow-up risk assessment Part 1: End of therapy risk assessment and management (escardio.org). Accessed 1 August 2024."},{"issue":"23","key":"10.1016\/j.apjon.2024.100597_bib19","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1200\/JCO.2015.65.6603","article-title":"Exercise and risk of cardiovascular events in women with nonmetastatic breast cancer","volume":"34","author":"Jones","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1016\/j.apjon.2024.100597_bib20","doi-asserted-by":"crossref","first-page":"e997","DOI":"10.1161\/CIR.0000000000000679","volume":"139","author":"Gilchrist","year":"2019","journal-title":"Circ"},{"issue":"11","key":"10.1016\/j.apjon.2024.100597_bib21","doi-asserted-by":"crossref","first-page":"S315","DOI":"10.1016\/j.cjca.2023.09.024","article-title":"Cardio-oncology and cancer rehabilitation: is an integrated approach possible?","volume":"39","author":"Pituskin","year":"2023","journal-title":"Can J Cardiol"},{"issue":"12","key":"10.1016\/j.apjon.2024.100597_bib22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jamacardio.2023.3558","article-title":"Cardio-oncology rehabilitation for cancer survivors with high cardiovascular risk: a randomized clinical trial","volume":"8","author":"Viamonte","year":"2023","journal-title":"JAMA cardiology"},{"key":"10.1016\/j.apjon.2024.100597_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwae181","article-title":"Cost-effectiveness analysis of a cardio-oncology rehabilitation framework compared to an exercise intervention for cancer survivors with high cardiovascular risk","author":"Viamonte","year":"2024","journal-title":"Eur J Prev Cardio"},{"key":"10.1016\/j.apjon.2024.100597_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ehjqcco\/qcaa039","article-title":"Shared Decision Making \u2013 the patient on the forefront of care coordination","volume":"6","author":"Hendriks","year":"2020","journal-title":"Eur Heart J - Qual Care Clin Outcomes"},{"key":"10.1016\/j.apjon.2024.100597_bib25","author":"Asteggiano"},{"issue":"6","key":"10.1016\/j.apjon.2024.100597_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/eurjcn\/zvac059","article-title":"Taking the patient on the scientific journey - making research findings patient friendly and inclusive","volume":"21","author":"Lee","year":"2022","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"4","key":"10.1016\/j.apjon.2024.100597_bib27","first-page":"754","article-title":"European society of cardiology core curriculum for cardio-oncology","volume":"26","author":"Lopez-Fernandez","year":"2024","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.apjon.2024.100597_bib28","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.jacc.2020.08.079","article-title":"Cardio-oncology education and training: JACC council perspectives","volume":"76","author":"Alvarez-Cardona","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.apjon.2024.100597_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40959-022-00140-3","article-title":"Early access to a cardio-oncology clinic in an Australian context: a qualitative exploration of patient experiences","volume":"8","author":"White","year":"2022","journal-title":"Cardio-Oncology"},{"issue":"1","key":"10.1016\/j.apjon.2024.100597_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjqcco\/qcac070","article-title":"European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment","volume":"9","author":"Lee","year":"2023","journal-title":"Eur Heart J \u2013 Qual Care Clin Outcomes"},{"key":"10.1016\/j.apjon.2024.100597_bib31","doi-asserted-by":"crossref","DOI":"10.1007\/s11864-024-01241-0","article-title":"The role of nursing in the delivery of cardio-oncology","author":"Fadol","year":"2024","journal-title":"Curr Treat Options Oncol"}],"container-title":["Asia-Pacific Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2347562524002191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2347562524002191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T15:20:38Z","timestamp":1732980038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2347562524002191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2347562524002191"],"URL":"https:\/\/doi.org\/10.1016\/j.apjon.2024.100597","relation":{},"ISSN":["2347-5625"],"issn-type":[{"value":"2347-5625","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiotoxicity in people undergoing cancer treatment - the role of the oncology nurse","name":"articletitle","label":"Article Title"},{"value":"Asia-Pacific Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apjon.2024.100597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of Asian Oncology Nursing Society.","name":"copyright","label":"Copyright"}],"article-number":"100597"}}